DIABETES & LIVER DISEASE RESOURCES
DIABETES & LIVER DISEASE RESOURCES
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common condition that often coexists with diabetes and other features of metabolic health. While frequently asymptomatic in its early stages, it can progress to significant liver and cardiovascular complications if not identified and managed early.
Improving awareness, identification and management is an important part of routine care. This resource hub was developed to support health professionals with practical resources, current evidence and guidance to deliver consistent, high-quality care across settings.
A curated collection of practical resources to support the identification and management of MAFLD in everyday care. These resources were developed to support clinical decision-making and build confidence across a range of care settings.
Access key guidelines and consensus statements to support the identification and management of MAFLD. These resources promote consistent, evidence-based care across clinical settings.
Key findings and emerging evidence in MAFLD, focusing on its connection to diabetes and metabolic health. Research supports a deeper understanding of disease progression and informs evolving care approaches.
Given the strong association between metabolic dysfunction-associated fatty liver disease (MAFLD), cardiovascular disease and chronic kidney disease, comprehensive risk assessment should extend beyond liver-specific measures to include broader metabolic and vascular risk.
